Prokidney Corp.
PROK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850270
In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $99.5M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Prokidney Corp. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 67 | 1 | 18 | −48 |
| Shares | 19.2M | 42.2K | 16.0M | −3.14M (−16.4%) |
| Value | $191.2M | $422.0K | $144.4M | −$46.4M (−24.3%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Prokidney Corp. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 10,351,656 | $93.3M | 0.01% |
| Suvretta Capital Management, LLC | 3,193,175 | $28.8M | 1.21% |
| Bleichroeder LP | 2,000,000 | $18.0M | 3.76% |
| Vanguard Group Inc | 152,100 | $1.37M | 0.00% |
| BlackRock Inc. | 108,802 | $980.0K | 0.00% |
| Geode Capital Management, LLC | 102,555 | $924.0K | 0.00% |
| Credit Suisse AG | 42,450 | $382.0K | 0.00% |
| Northern Trust Corp | 18,702 | $169.0K | 0.00% |
| Compagnie Lombard Odier SCmA | 10,500 | $95.0K | 0.00% |
| US Bancorp | 1,000 | $9.00K | 0.00% |
| Wells Fargo & Company | 69 | $1.00K | 0.00% |
| Signaturefd, LLC | 60 | $1.00K | 0.00% |
Sold out (60)
Institutions that held Prokidney Corp. at the end of Q2 2022 and filed for Q3 2022 without it.
Not filed for Q3 2022 yet (1)
Institutions that held Prokidney Corp. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exos Asset Management LLC | 42,201 | $422.0K |